182 related articles for article (PubMed ID: 19501884)
1. Time-lapse live cell imaging and flow analysis of multidrug resistance reversal by verapamil in bladder cancer cell lines.
Featherstone JM; Lwaleed BA; Speers AG; Hayes MC; Birch BR; Cooper AJ
Urology; 2009 Aug; 74(2):378-84. PubMed ID: 19501884
[TBL] [Abstract][Full Text] [Related]
2. The nuclear membrane in multidrug resistance: microinjection of epirubicin into bladder cancer cell lines.
Featherstone JM; Speers AG; Lwaleed BA; Hayes MC; Cooper AJ; Birch BR
BJU Int; 2005 May; 95(7):1091-8. PubMed ID: 15839939
[TBL] [Abstract][Full Text] [Related]
3. Multidrug resistance in a urothelial cancer cell line after 3, 1-hour exposures to mitomycin C.
Speers AG; Lwaleed BA; Featherstone JM; Cooper AJ
J Urol; 2007 Nov; 178(5):2171-5. PubMed ID: 17870115
[TBL] [Abstract][Full Text] [Related]
4. Epirubicin and meglumine gamma-linolenic acid: a logical choice of combination therapy for patients with superficial bladder carcinoma.
Harris NM; Anderson WR; Lwaleed BA; Cooper AJ; Birch BR; Solomon LZ
Cancer; 2003 Jan; 97(1):71-8. PubMed ID: 12491507
[TBL] [Abstract][Full Text] [Related]
5. Multidrug resistance in a urothelial cancer cell line after 1-hour mitomycin C exposure.
Birare N; Lwaleed BA; Cooper AJ
J Urol; 2009 Nov; 182(5):2472-6. PubMed ID: 19765756
[TBL] [Abstract][Full Text] [Related]
6. Localization of anthracycline accumulation in sensitive and resistant urothelial tumor cell lines.
Davies CL; Duffy PM; MacRobert AJ; Loizidou MC; Cooper AJ; Taylor I
Cancer Detect Prev; 1996; 20(6):625-33. PubMed ID: 8939349
[TBL] [Abstract][Full Text] [Related]
7. Intravesical pH: a potentially important variable affecting efficacy and the further development of anthracycline chemotherapy for superficial bladder cancer.
Harris NM; Duffy PM; Crook TJ; Anderson WR; Sharpe P; Hayes MC; Cooper AJ; Solomon LZ
BJU Int; 2002 Dec; 90(9):957-64. PubMed ID: 12460364
[TBL] [Abstract][Full Text] [Related]
8. Estramustine reversal of resistance to intravesical epirubicin chemotherapy.
Jennings AM; Solomon LZ; Sharpe P; Hayes MC; Cooper AJ; Birch BR
Eur Urol; 1999 Apr; 35(4):327-35. PubMed ID: 10087397
[TBL] [Abstract][Full Text] [Related]
9. Comparison of effects of surfactants with other MDR reversing agents on intracellular uptake of epirubicin in Caco-2 cell line.
Lo YL; Hsu CY; Huang JD
Anticancer Res; 1998; 18(4C):3005-9. PubMed ID: 9713500
[TBL] [Abstract][Full Text] [Related]
10. Reversal of multidrug resistance by synthetic and natural compounds in drug-resistant MCF-7 cell lines.
Kars MD; Işeri OD; Gunduz U; Molnar J
Chemotherapy; 2008; 54(3):194-200. PubMed ID: 18560226
[TBL] [Abstract][Full Text] [Related]
11. Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells.
Koo JS; Choi WC; Rhee YH; Lee HJ; Lee EO; Ahn KS; Bae HS; Ahn KS; Kang JM; Choi SU; Kim MO; Lu J; Kim SH
Life Sci; 2008 Nov; 83(21-22):700-8. PubMed ID: 18845169
[TBL] [Abstract][Full Text] [Related]
12. [Experimental study on thermochemotherapy combined with verapamil for reversing the multidrug resistance responsible to breast cancer cell].
Yan X; Hou M; Li SF; Liu YY
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 May; 39(3):391-3. PubMed ID: 18575322
[TBL] [Abstract][Full Text] [Related]
13. Determination and reversal of resistance to epirubicin intravesical chemotherapy. A flow cytometric model.
Duffy PM; Hayes MC; Cooper A; Smart CJ
Br J Urol; 1996 Jun; 77(6):819-23. PubMed ID: 8705214
[TBL] [Abstract][Full Text] [Related]
14. Reversal of multidrug resistance of cancer cells in vitro: modification of drug resistance by selected carotenoids.
Gyémánt N; Tanaka M; Molnár P; Deli J; Mándoky L; Molnár J
Anticancer Res; 2006; 26(1A):367-74. PubMed ID: 16475720
[TBL] [Abstract][Full Text] [Related]
15. Determination and reversal of resistance to epirubicin intravesical chemotherapy. A confocal imaging study.
Duffy PM; Hayes MC; Gatrell SK; Cooper A; Smart CJ
Br J Urol; 1996 Jun; 77(6):824-9. PubMed ID: 8705215
[TBL] [Abstract][Full Text] [Related]
16. Inhibit multidrug resistance and induce apoptosis by using glycocholic acid and epirubicin.
Lo YL; Ho CT; Tsai FL
Eur J Pharm Sci; 2008 Sep; 35(1-2):52-67. PubMed ID: 18606222
[TBL] [Abstract][Full Text] [Related]
17. Reversal of multidrug resistance to epirubicin by cyclosporin A in liposomes or intralipid.
Lo YL; Liu FI; Yang JM; Cherng JY
Anticancer Res; 2001; 21(1A):445-50. PubMed ID: 11299776
[TBL] [Abstract][Full Text] [Related]
18. Furosemide reverses multidrug resistance status in bladder cancer cells in vitro.
Speers AG; Lwaleed BA; Featherstone JM; Sallis BJ; Cooper AJ
J Clin Pathol; 2006 Sep; 59(9):912-5. PubMed ID: 16556663
[TBL] [Abstract][Full Text] [Related]
19. Combined Fourier transform infrared and Raman spectroscopic approach for identification of multidrug resistance phenotype in cancer cell lines.
Krishna CM; Kegelaer G; Adt I; Rubin S; Kartha VB; Manfait M; Sockalingum GD
Biopolymers; 2006 Aug; 82(5):462-70. PubMed ID: 16493658
[TBL] [Abstract][Full Text] [Related]
20. Reversal effect of isotetrandrine, an isoquinoline alkaloid extracted from Caulis Mahoniae, on P-glycoprotein-mediated doxorubicin-resistance in human breast cancer (MCF-7/DOX) cells.
Wang TX; Yang XH
Yao Xue Xue Bao; 2008 May; 43(5):461-6. PubMed ID: 18717331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
